首页|期刊导航|中国医学创新|富血小板血浆宫腔灌注联合雌二醇片/雌二醇地屈孕酮片复合包装治疗宫腔镜下粘连分离术后患者的效果

富血小板血浆宫腔灌注联合雌二醇片/雌二醇地屈孕酮片复合包装治疗宫腔镜下粘连分离术后患者的效果OA

Efficacy of Intrauterine Perfusion of Platelet-rich Plasma Combined with Complex Packing Estradiol Tablets/Estradiol and Dydrogesterone Tablets in Patients after Transcervical Resection of Adhesions

中文摘要英文摘要

目的:探究富血小板血浆宫腔灌注联合雌二醇片/雌二醇地屈孕酮片复合包装对宫腔镜下粘连分离术(TCRA)后患者的疗效.方法:回顾性选取 2024 年 5 月—2025 年 4 月上饶市立医院符合子宫腔粘连诊断标准且刚完成 TCRA 的患者 80 例作为研究对象,术后接受常规干预者为对照组(n=40),术后接受富血小板血浆宫腔灌注联合雌二醇片/雌二醇地屈孕酮片复合包装治疗者为观察组(n=40).对比两组子宫内膜相关指标、子宫腔再粘连程度、月经失血图(PBAC)评分、月经恢复及安全性.结果:观察组术后 6 个月的搏动指数(PI)、阻力指数(RI)、子宫动脉收缩期峰值流速(PSV)差值均较对照组大(P<0.05).观察组术后 3、6 个月的子宫腔再粘连程度评分较对照组低,PBAC 评分较对照组高(P<0.05).观察组术后 6 个月的月经复潮率较对照组高,术后 3、6 个月的月经周期天数、月经持续天数较对照组长(P<0.05).观察组不良反应总发生率较对照组低(P<0.05).结论:富血小板血浆宫腔灌注联合雌二醇片/雌二醇地屈孕酮片复合包装,能够有效改善 TCRA 后患者子宫内膜相关指标,降低子宫腔再粘连程度,促进月经恢复正常且安全性较高.

Objective:To investigate the efficacy of intrauterine perfusion of platelet-rich plasma combined with Complex Packing Estradiol Tablets/Estradiol and Dydrogesterone Tablets in patients after transcervical resection of adhesions(TCRA).Method:A retrospective selection was made of 80 patients who met the diagnostic criteria for intrauterine adhesions and had just undergone TCRA between May 2024 and April 2025 in Shangrao Municipal Hospital as the study subjects.The control group(n=40)received conventional postoperative interventions,while the observation group(n=40)received intrauterine perfusion of platelet-rich plasma combined with Complex Packing Estradiol Tablets/Estradiol and Dydrogesterone Tablets.Endometrial-related indicators,degree of intrauterine re-adhesion,pictorial blood loss assessment chart(PBAC)score,menstrual recovery and safety were compared between the two groups.Result:At 6 months postoperatively,the differences in pulsatility index(PI),resistance index(RI),and peak systolic velocity(PSV)of the uterine artery were greater in the observation group than in the control group(P<0.05).The scores for the degree of intrauterine re-adhesion at 3 and 6 months after postoperatively were lower in the observation group,while PBAC scores were higher compared to the control group(P<0.05).The resumption rate at 6 months postoperatively was higher,menstrual cycle length and duration at 3 and 6 months after postoperatively were longer in the observation group compared to the control group(P<0.05).The total incidence of adverse reactions was lower in the observation group compared to the control group(P<0.05).Conclusion:Intrauterine perfusion of platelet-rich plasma combined with Complex Packing Estradiol Tablets/Estradiol and Dydrogesterone Tablets can effectively improve endometrial-related indicators in patients after TCRA,reduce the degree of intrauterine re-adhesion,promote the recovery of normal menstruation,and has a high safety profile.

邱模晖;余海丽;翁莉

上饶市立医院妇产科 江西 上饶 334000上饶市妇幼保健院药剂科 江西 上饶 334000上饶市中医院妇产科 江西 上饶 334000

医药卫生

富血小板血浆宫腔灌注雌二醇片/雌二醇地屈孕酮片复合包装宫腔镜下粘连分离术

Platelet-rich plasmaIntrauterine perfusionComplex Packing Estradiol Tablets/Estradiol and Dydrogesterone TabletsTranscervical resection of adhesions

《中国医学创新》 2026 (23)

39-43,5

上饶市社会发展领域科技计划项目(20251CZDX25)

10.3969/j.issn.1674-4985.2026.23.009

评论